Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $8.27 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.24.
Market Cap
8.27T
Revenue
4.59T
Profits
200.63B
PE Ratio
41.24
Profit Margin
4.37%
Dividend Yield
0.43%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 904.90B | -0.65% | 1,873,392 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 551.99B | -0.30% | 3,142,219 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 377.31B | -0.10% | 2,831,780 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 348.15B | -1.51% | 5,763,138 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 290.91B | 1.48% | 1,339,281 | 60.44B |
| 6 | NVS | Novartis AG | 287.34B | 0.11% | 1,023,827 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 279.11B | -1.08% | 4,935,911 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 198.88B | 2.17% | 8,467,881 | 50.57B |
| 9 | AMGN | Amgen Inc. | 179.10B | 0.33% | 2,465,323 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 167.11B | 0.42% | 2,272,076 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 162.66B | 0.39% | 3,425,827 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 159.19B | 1.79% | 1,189,563 | 10.58B |
| 13 | ABT | Abbott Laboratories | 154.55B | -0.10% | 5,561,226 | 45.13B |
| 14 | PFE | Pfizer Inc. | 147.36B | 0.76% | 27,801,892 | 63.32B |
| 15 | SYK | Stryker Corporation | 123.15B | 1.10% | 2,261,940 | 25.27B |
| 16 | DHR | Danaher Corporation | 121.05B | 2.39% | 3,042,051 | 24.78B |
| 17 | BMY | Bristol-Myers Squibb Company | 119.51B | 0.37% | 4,679,631 | 48.48B |
| 18 | CVS | CVS Health Corporation | 119.44B | -0.61% | 5,465,175 | 405.62B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 109.04B | -1.08% | 1,324,621 | 12.22B |
| 20 | SNY | Sanofi | 104.65B | 2.85% | 2,466,084 | 54.60B |
| 21 | GSK | GSK plc | 101.90B | -0.58% | 2,246,043 | 43.29B |
| 22 | MDT | Medtronic plc | 100.24B | -0.64% | 7,011,655 | 35.48B |
| 23 | MCK | McKesson Corporation | 91.11B | -0.52% | 737,390 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 88.39B | -1.54% | 1,713,823 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 85.93B | -1.64% | 847,696 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 84.60B | 0.19% | 11,476,644 | 20.61B |
| 27 | CI | The Cigna Group | 74.90B | -2.79% | 779,078 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 66.02B | 2.96% | 787,879 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 52.28B | 0.63% | 1,495,683 | 28.34B |
| 30 | COR | Cencora, Inc. | 51.50B | -0.54% | 1,508,976 | 328.68B |
| 31 | ARGX | argenx SE | 49.93B | 0.43% | 260,235 | 4.74B |
| 32 | MDLN | Medline Inc. | 47.87B | -3.34% | 7,229,428 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 47.70B | 0.83% | 2,973,838 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 46.67B | -0.56% | 1,382,370 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.68B | 1.32% | 407,225 | 4.45B |
| 36 | HLN | Haleon plc | 40.65B | 1.03% | 6,546,351 | 14.85B |
| 37 | BDX | Becton, Dickinson and Company | 40.39B | -0.24% | 1,913,012 | 22.23B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 39.96B | 0.72% | 4,271,594 | 17.35B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.87B | 1.46% | 511,719 | 4.29B |
| 40 | HUM | Humana Inc. | 36.64B | -1.73% | 1,033,879 | 137.20B |
| 41 | ONC | BeOne Medicines AG | 34.20B | 3.57% | 226,345 | 5.70B |
| 42 | WAT | Waters Corporation | 33.43B | 2.15% | 668,047 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 33.41B | 0.99% | 5,625,029 | 9.53B |
| 44 | ALC | Alcon Inc. | 32.82B | 1.46% | 2,405,757 | 10.63B |
| 45 | A | Agilent Technologies, Inc. | 32.11B | 2.75% | 2,186,376 | 7.07B |
| 46 | RVMD | Revolution Medicines, Inc. | 31.96B | 2.06% | 1,914,954 | - |
| 47 | RMD | ResMed Inc. | 30.61B | 1.56% | 1,259,689 | 5.54B |
| 48 | RPRX | Royalty Pharma plc | 30.54B | 1.18% | 1,820,866 | 2.44B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 29.22B | 4.32% | 6,181,842 | 20.98B |
| 50 | NTRA | Natera, Inc. | 29.17B | 3.90% | 1,223,386 | 2.50B |
| 51 | CNC | Centene Corporation | 28.80B | -1.39% | 2,129,184 | 178.33B |
| 52 | IQV | IQVIA Holdings Inc. | 28.63B | -0.96% | 1,795,725 | 16.63B |
| 53 | BIIB | Biogen Inc. | 27.74B | -1.41% | 576,923 | 9.94B |
| 54 | DXCM | DexCom, Inc. | 27.57B | 6.74% | 9,290,762 | 4.82B |
| 55 | VEEV | Veeva Systems Inc. | 26.94B | 1.07% | 1,385,057 | 3.20B |
| 56 | PHG | Koninklijke Philips N.V. | 25.38B | 2.65% | 1,403,009 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 23.95B | -0.45% | 359,977 | 3.17B |
| 58 | INSM | Insmed Incorporated | 23.36B | 0.34% | 2,438,689 | 819.56M |
| 59 | ROIV | Roivant Sciences Ltd. | 23.18B | 14.80% | 14,976,886 | 13.31M |
| 60 | BNTX | BioNTech SE | 22.87B | 3.00% | 641,342 | 3.23B |
| 61 | MTD | Mettler-Toledo International Inc. | 21.85B | 2.88% | 160,498 | 4.09B |
| 62 | WST | West Pharmaceutical Services, Inc. | 21.58B | 0.51% | 335,183 | 3.22B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.44B | 1.73% | 670,906 | 11.28B |
| 64 | ILMN | Illumina, Inc. | 21.42B | -0.08% | 1,075,801 | 4.39B |
| 65 | STE | STERIS plc | 21.11B | 0.39% | 620,936 | 5.94B |
| 66 | LH | Labcorp Holdings Inc. | 21.08B | 1.34% | 287,070 | 14.14B |
| 67 | INCY | Incyte Corporation | 19.41B | 1.64% | 626,472 | 5.36B |
| 68 | VTRS | Viatris Inc. | 19.34B | 2.72% | 7,788,427 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 19.15B | 5.58% | 3,614,442 | 2.23B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 16.51B | -0.84% | 1,766,574 | 8.41B |
| 71 | GMAB | Genmab A/S | 16.45B | 5.98% | 5,328,506 | 3.90B |
| 72 | THC | Tenet Healthcare Corporation | 16.18B | -1.88% | 1,442,964 | 21.46B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.55B | 0.21% | 829,244 | 3.10B |
| 74 | GH | Guardant Health, Inc. | 15.25B | 17.09% | 3,776,303 | 1.08B |
| 75 | ASND | Ascendis Pharma A/S | 15.01B | 1.56% | 402,390 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.00B | 0.70% | 705,322 | 4.44B |
| 77 | SMMT | Summit Therapeutics Inc. | 13.91B | 13.09% | 3,731,897 | - |
| 78 | RGC | Regencell Bioscience Holdings Limited | 13.79B | 3.31% | 38,378 | - |
| 79 | BBIO | BridgeBio Pharma, Inc. | 13.37B | 3.44% | 2,211,687 | 579.96M |
| 80 | SNN | Smith & Nephew plc | 13.24B | 0.45% | 1,087,345 | 6.16B |
| 81 | SOLV | Solventum Corporation | 13.12B | 1.36% | 927,029 | 8.26B |
| 82 | PEN | Penumbra, Inc. | 12.88B | 0.25% | 333,837 | 1.45B |
| 83 | DVA | DaVita Inc. | 12.64B | 1.15% | 418,378 | 13.84B |
| 84 | EXEL | Exelixis, Inc. | 12.52B | 2.34% | 1,622,884 | 2.38B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.40B | 1.64% | 1,575,627 | 1.06B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.07B | 3.47% | 1,984,759 | 13.65B |
| 87 | COO | The Cooper Companies, Inc. | 12.06B | 0.60% | 3,066,622 | 4.15B |
| 88 | MEDP | Medpace Holdings, Inc. | 12.03B | 0.27% | 316,237 | 2.68B |
| 89 | AXSM | Axsome Therapeutics, Inc. | 11.94B | 2.35% | 514,332 | 708.24M |
| 90 | FMS | Fresenius Medical Care AG | 11.94B | 0.23% | 510,860 | 22.32B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.84B | 0.36% | 224,613 | 1.13B |
| 92 | ALGN | Align Technology, Inc. | 11.70B | 5.26% | 1,121,519 | 4.10B |
| 93 | GMED | Globus Medical, Inc. | 11.40B | 5.07% | 1,989,568 | 3.10B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.40B | 1.26% | 1,429,874 | 3.58B |
| 95 | PODD | Insulet Corporation | 10.89B | 1.67% | 830,103 | 2.90B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.88B | 5.51% | 1,112,256 | 622.01M |
| 97 | CYTK | Cytokinetics, Incorporated | 10.68B | 2.92% | 1,976,976 | 105.82M |
| 98 | RVTY | Revvity, Inc. | 10.59B | -1.00% | 928,525 | 2.90B |
| 99 | EHC | Encompass Health Corporation | 10.50B | 1.03% | 416,048 | 6.07B |
| 100 | ELAN | Elanco Animal Health Incorporated | 10.43B | 5.45% | 6,695,424 | 4.89B |
| 101 | ENSG | The Ensign Group, Inc. | 10.31B | 1.15% | 254,090 | 5.27B |
| 102 | UHS | Universal Health Services, Inc. | 9.95B | -1.24% | 490,338 | 17.76B |
| 103 | BAX | Baxter International Inc. | 9.70B | 2.51% | 5,006,611 | 11.32B |
| 104 | BMRN | BioMarin Pharmaceutical Inc. | 9.70B | 0.72% | 1,681,413 | 3.24B |
| 105 | ABVX | ABIVAX Sociรฉtรฉ Anonyme | 9.54B | 5.34% | 1,147,079 | 5.37M |
| 106 | MOH | Molina Healthcare, Inc. | 9.46B | -1.51% | 694,282 | 43.10B |
| 107 | MASI | Masimo Corporation | 9.36B | -0.01% | 670,339 | 1.56B |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 9.29B | 3.94% | 219,899 | 7.46M |
| 109 | KRYS | Krystal Biotech, Inc. | 8.89B | 2.77% | 151,505 | 417.30M |
| 110 | ICLR | ICON Public Limited Company | 8.81B | 1.55% | 575,037 | 8.10B |
| 111 | IBRX | ImmunityBio, Inc. | 8.51B | 4.70% | 22,618,159 | 140.98M |
| 112 | GKOS | Glaukos Corporation | 8.47B | 3.07% | 742,768 | 551.35M |
| 113 | HSIC | Henry Schein, Inc. | 8.34B | 0.34% | 910,693 | 13.38B |
| 114 | TEM | Tempus AI, Inc. | 8.19B | 0.20% | 3,809,650 | 1.36B |
| 115 | HALO | Halozyme Therapeutics, Inc. | 8.19B | 0.47% | 935,620 | 1.51B |
| 116 | NUVL | Nuvalent, Inc. | 8.08B | 1.28% | 317,665 | - |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 7.67B | 2.02% | 385,253 | 2.59B |
| 118 | CRL | Charles River Laboratories International, Inc. | 7.50B | 2.20% | 676,975 | 4.03B |
| 119 | HQY | HealthEquity, Inc. | 7.39B | 3.38% | 972,515 | 1.31B |
| 120 | ATR | AptarGroup, Inc. | 7.33B | 1.08% | 389,992 | 3.87B |
| 121 | TECH | Bio-Techne Corporation | 7.31B | 2.75% | 2,070,071 | 1.21B |
| 122 | QGEN | Qiagen N.V. | 7.25B | 2.44% | 1,321,180 | 2.10B |
| 123 | IMVT | Immunovant, Inc. | 7.20B | 34.52% | 18,443,677 | - |
| 124 | OSCR | Oscar Health, Inc. | 7.03B | -4.81% | 5,359,255 | 13.30B |
| 125 | PCVX | Vaxcyte, Inc. | 6.81B | -3.26% | 3,743,062 | - |
| 126 | CELC | Celcuity Inc. | 6.80B | 6.41% | 661,785 | - |
| 127 | BRKR | Bruker Corporation | 6.74B | 3.97% | 1,392,124 | 3.46B |
| 128 | KYMR | Kymera Therapeutics, Inc. | 6.66B | 3.61% | 405,293 | 51.48M |
| 129 | GRFS | Grifols, S.A. | 6.52B | 4.66% | 1,033,807 | 8.58B |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.50B | 2.70% | 261,639 | 74.06M |
| 131 | CORT | Corcept Therapeutics Incorporated | 6.35B | 1.55% | 900,412 | 769.10M |
| 132 | RGEN | Repligen Corporation | 6.28B | 2.66% | 953,888 | 763.34M |
| 133 | LNTH | Lantheus Holdings, Inc. | 6.26B | 3.43% | 541,696 | 1.55B |
| 134 | SYRE | Spyre Therapeutics, Inc. | 6.24B | 7.94% | 876,319 | - |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.21B | 3.97% | 346,234 | 217.17M |
| 136 | ALKS | Alkermes plc | 6.17B | -0.03% | 1,386,759 | 1.56B |
| 137 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.13% | 769,383 | 15.00M |
| 138 | APGE | Apogee Therapeutics, Inc. | 6.11B | 4.17% | 581,579 | - |
| 139 | TFX | Teleflex Incorporated | 6.00B | 2.07% | 507,250 | 2.13B |
| 140 | MIRM | Mirum Pharmaceuticals, Inc. | 5.91B | 1.25% | 380,981 | 569.61M |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.90B | 1.22% | 790,638 | 827.11M |
| 142 | PACS | PACS Group, Inc. | 5.82B | 0.16% | 487,952 | 5.43B |
| 143 | CHE | Chemed Corporation | 5.82B | 0.01% | 136,923 | 2.54B |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.79B | 1.66% | 658,148 | - |
| 145 | BLCO | Bausch + Lomb Corporation | 5.77B | -0.15% | 286,370 | 5.21B |
| 146 | CGON | CG Oncology, Inc. | 5.72B | 2.45% | 598,638 | 5.07M |
| 147 | BLTE | Belite Bio, Inc | 5.65B | 2.79% | 234,164 | - |
| 148 | TGTX | TG Therapeutics, Inc. | 5.64B | 0.90% | 990,723 | 700.35M |
| 149 | COGT | Cogent Biosciences, Inc. | 5.64B | 5.54% | 1,447,233 | - |
| 150 | LQDA | Liquidia Corporation | 5.50B | 3.03% | 1,415,856 | 288.07M |
| 151 | AVTR | Avantor, Inc. | 5.36B | 2.81% | 19,917,290 | 6.55B |
| 152 | HIMS | Hims & Hers Health, Inc. | 5.34B | 2.74% | 14,003,020 | 2.37B |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.28B | 1.11% | 788,983 | 7.50M |
| 154 | LEGN | Legend Biotech Corporation | 5.23B | 4.60% | 1,152,598 | 1.14B |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 4.86B | 3.70% | 572,800 | 1.34M |
| 156 | STVN | Stevanato Group S.p.A. | 4.85B | 2.60% | 310,895 | 1.39B |
| 157 | CRSP | CRISPR Therapeutics AG | 4.69B | 2.26% | 1,411,765 | 4.10M |
| 158 | CAI | Caris Life Sciences, Inc. | 4.47B | 5.82% | 2,075,002 | 907.29M |
| 159 | SHC | Sotera Health Company | 4.43B | 2.07% | 1,865,273 | 1.19B |
| 160 | MANE | Veradermics, Incorporated | 4.41B | 6.91% | 309,640 | - |
| 161 | LGND | Ligand Pharmaceuticals Incorporated | 4.37B | 5.03% | 161,474 | 274.48M |
| 162 | RDNT | RadNet, Inc. | 4.25B | 1.39% | 271,630 | 2.14B |
| 163 | HNGE | Hinge Health, Inc. | 4.22B | -0.76% | 799,323 | 646.34M |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.16B | 1.46% | 329,786 | 754.05M |
| 165 | NAMS | NewAmsterdam Pharma Company N.V. | 4.10B | 5.75% | 1,068,844 | 22.57M |
| 166 | TVTX | Travere Therapeutics, Inc. | 4.05B | 3.01% | 1,292,679 | 536.20M |
| 167 | LIVN | LivaNova PLC | 4.04B | 0.97% | 496,441 | 1.43B |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 3.90B | 3.39% | 1,034,711 | 3.05B |
| 169 | NVST | Envista Holdings Corporation | 3.86B | 3.02% | 4,888,280 | 2.81B |
| 170 | MMSI | Merit Medical Systems, Inc. | 3.85B | 1.11% | 279,586 | 1.54B |
| 171 | IRTC | iRhythm Holdings, Inc. | 3.84B | 2.60% | 235,406 | 787.85M |
| 172 | BLLN | BillionToOne, Inc. | 3.83B | 1.20% | 562,548 | 354.54M |
| 173 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.83B | 3.89% | 529,011 | 18.07M |
| 174 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | 0.10% | 1,913,073 | 596.96M |
| 175 | WAY | Waystar Holding Corp. | 3.67B | -2.50% | 1,926,414 | 1.16B |
| 176 | ORKA | Oruka Therapeutics, Inc. | 3.66B | 5.46% | 1,303,041 | - |
| 177 | DOCS | Doximity, Inc. | 3.63B | 3.12% | 3,332,506 | 644.86M |
| 178 | VCYT | Veracyte, Inc. | 3.61B | 8.56% | 832,956 | 541.74M |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 3.59B | 2.32% | 1,328,050 | 1.10B |
| 180 | OGN | Organon & Co. | 3.53B | 0.30% | 1,899,031 | 6.16B |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.53B | 4.52% | 577,194 | - |
| 182 | OPCH | Option Care Health, Inc. | 3.48B | 6.38% | 3,911,443 | 5.67B |
| 183 | ALHC | Alignment Healthcare, Inc. | 3.45B | 1.89% | 2,635,471 | 4.26B |
| 184 | ERAS | Erasca, Inc. | 3.43B | 6.78% | 5,634,511 | - |
| 185 | VKTX | Viking Therapeutics, Inc. | 3.42B | 3.73% | 1,310,617 | - |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.40B | 0.88% | 86,455 | 803.79M |
| 187 | TWST | Twist Bioscience Corporation | 3.34B | 8.30% | 1,198,912 | 409.48M |
| 188 | MMED | MiniMed Group, Inc. | 3.26B | 6.61% | 708,385 | 2.99B |
| 189 | CON | Concentra Group Holdings Parent, Inc. | 3.25B | -0.47% | 570,889 | 2.23B |
| 190 | ICUI | ICU Medical, Inc. | 3.21B | 4.02% | 209,879 | 2.16B |
| 191 | BKD | Brookdale Senior Living Inc. | 3.18B | 0.42% | 2,209,660 | 3.00B |
| 192 | ITGR | Integer Holdings Corporation | 3.10B | 1.05% | 270,272 | 1.86B |
| 193 | NHC | National HealthCare Corporation | 3.10B | 1.20% | 69,409 | 1.53B |
| 194 | TNGX | Tango Therapeutics, Inc. | 3.06B | 4.14% | 2,851,895 | 56.99M |
| 195 | TXG | 10x Genomics, Inc. | 3.05B | 7.72% | 2,457,082 | 638.78M |
| 196 | DNLI | Denali Therapeutics Inc. | 2.99B | 4.20% | 1,010,564 | - |
| 197 | WRBY | Warby Parker Inc. | 2.99B | -4.41% | 5,046,558 | 890.57M |
| 198 | RCUS | Arcus Biosciences, Inc. | 2.99B | 4.48% | 608,967 | 236.00M |
| 199 | LFST | LifeStance Health Group, Inc. | 2.98B | -0.65% | 2,177,210 | 1.49B |
| 200 | PRVA | Privia Health Group, Inc. | 2.92B | -0.52% | 377,997 | 2.25B |
| 201 | DYN | Dyne Therapeutics, Inc. | 2.90B | 10.27% | 1,383,969 | - |
| 202 | GRAL | GRAIL, Inc. | 2.84B | 8.67% | 581,039 | 156.12M |
| 203 | SUPN | Supernus Pharmaceuticals, Inc. | 2.83B | 2.35% | 448,673 | 776.83M |
| 204 | ALMS | Alumis Inc. | 2.80B | 1.88% | 592,404 | 8.40M |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 2.79B | 5.76% | 379,451 | 535.08M |
| 206 | HAE | Haemonetics Corporation | 2.75B | 4.19% | 785,760 | 1.33B |
| 207 | BEAM | Beam Therapeutics Inc. | 2.70B | 3.15% | 1,666,875 | 164.01M |
| 208 | GPCR | Structure Therapeutics Inc. | 2.62B | 2.87% | 1,139,117 | - |
| 209 | IDYA | IDEAYA Biosciences, Inc. | 2.61B | 4.84% | 531,381 | 225.27M |
| 210 | GMRS | GMR Solutions Inc. | 2.60B | -3.48% | 2,850,841 | 5.74B |
| 211 | KLRA | Kailera Therapeutics, Inc. | 2.59B | 2.09% | 183,115 | - |
| 212 | IRON | Disc Medicine, Inc. | 2.57B | 5.06% | 339,559 | - |
| 213 | ARQT | Arcutis Biotherapeutics, Inc. | 2.56B | 5.00% | 1,542,060 | 415.62M |
| 214 | ELVN | Enliven Therapeutics, Inc. | 2.55B | 4.14% | 512,179 | - |
| 215 | RLAY | Relay Therapeutics, Inc. | 2.50B | 7.95% | 5,611,349 | 10.68M |
| 216 | VERA | Vera Therapeutics, Inc. | 2.48B | 3.97% | 602,813 | - |
| 217 | IMNM | Immunome, Inc. | 2.45B | 9.82% | 1,002,679 | 4.02M |
| 218 | CLDX | Celldex Therapeutics, Inc. | 2.42B | 2.45% | 598,318 | 865.00K |
| 219 | TMDX | TransMedics Group, Inc. | 2.37B | 3.90% | 1,017,191 | 635.89M |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.37B | 3.36% | 308,713 | 1.46B |
| 221 | HTFL | HeartFlow, Inc. | 2.35B | 2.44% | 885,933 | 191.42M |
| 222 | MLYS | Mineralys Therapeutics, Inc. | 2.34B | 9.10% | 3,956,509 | - |
| 223 | NKTR | Nektar Therapeutics | 2.33B | 2.20% | 654,274 | 55.63M |
| 224 | LMAT | LeMaitre Vascular, Inc. | 2.32B | 0.29% | 183,207 | 256.28M |
| 225 | RARE | Ultragenyx Pharmaceutical Inc. | 2.30B | 4.14% | 1,122,120 | 670.00M |
| 226 | DFTX | Definium Therapeutics, Inc. | 2.28B | 4.25% | 1,108,305 | - |
| 227 | AXGN | Axogen, Inc. | 2.27B | -0.19% | 683,358 | 238.11M |
| 228 | KOD | Kodiak Sciences Inc. | 2.26B | 5.32% | 528,951 | - |
| 229 | PBH | Prestige Consumer Healthcare Inc. | 2.25B | 2.50% | 421,355 | 1.09B |
| 230 | ADPT | Adaptive Biotechnologies Corporation | 2.22B | 7.25% | 1,551,009 | 295.41M |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.22B | -0.23% | 1,766,648 | 885.72M |
| 232 | ACHC | Acadia Healthcare Company, Inc. | 2.21B | -3.49% | 1,132,687 | 3.37B |
| 233 | ZLAB | Zai Lab Limited | 2.11B | 2.20% | 600,207 | 453.28M |
| 234 | NBTX | Nanobiotix S.A. | 2.08B | -6.54% | 91,149 | 38.27M |
| 235 | ESTA | Establishment Labs Holdings Inc. | 2.07B | 7.43% | 335,900 | 229.58M |
| 236 | NVCR | NovoCure Limited | 2.06B | 4.38% | 1,053,785 | 674.41M |
| 237 | BHC | Bausch Health Companies Inc. | 2.05B | 3.38% | 1,654,807 | 10.53B |
| 238 | HCM | HUTCHMED (China) Limited | 2.05B | -1.16% | 13,592 | 548.51M |
| 239 | SEM | Select Medical Holdings Corporation | 2.05B | 0.24% | 3,360,965 | 5.52B |
| 240 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | 2.32% | 1,145,162 | 298.30M |
| 241 | OMCL | Omnicell, Inc. | 2.03B | 1.67% | 237,430 | 1.23B |
| 242 | TYRA | Tyra Biosciences, Inc. | 2.00B | -0.27% | 902,722 | - |
| 243 | PGNY | Progyny, Inc. | 2.00B | 3.72% | 1,650,283 | 1.29B |
| 244 | ADMA | ADMA Biologics, Inc. | 1.98B | -0.81% | 3,444,370 | 509.86M |
| 245 | TRVI | Trevi Therapeutics, Inc. | 1.97B | 4.76% | 1,038,994 | - |
| 246 | XRAY | DENTSPLY SIRONA Inc. | 1.97B | 0.82% | 5,438,468 | 3.68B |
| 247 | VRDN | Viridian Therapeutics, Inc. | 1.94B | 10.02% | 2,798,891 | 70.92M |
| 248 | PHVS | Pharvaris N.V. | 1.93B | 1.87% | 170,554 | - |
| 249 | ASTH | Astrana Health, Inc. | 1.92B | -1.55% | 196,030 | 3.53B |
| 250 | NEOG | Neogen Corporation | 1.91B | 5.33% | 2,691,938 | 870.56M |
| 251 | CLOV | Clover Health Investments, Corp. | 1.89B | 2.71% | 5,369,189 | 2.21B |
| 252 | STOK | Stoke Therapeutics, Inc. | 1.88B | 0.70% | 458,838 | 32.08M |
| 253 | MESO | Mesoblast Limited | 1.83B | -0.55% | 193,336 | 65.38M |
| 254 | AAPG | Ascentage Pharma Group International | 1.82B | 5.32% | 10,593 | 82.08M |
| 255 | ZYME | Zymeworks Inc. | 1.82B | 1.91% | 390,339 | 81.26M |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 1.81B | 2.99% | 496,278 | 899.11M |
| 257 | SRPT | Sarepta Therapeutics, Inc. | 1.81B | 3.00% | 1,713,898 | 2.18B |
| 258 | PLSE | Pulse Biosciences, Inc. | 1.81B | 4.73% | 190,174 | 751.00K |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.80B | 2.84% | 123,231 | 1.20B |
| 260 | VCEL | Vericel Corporation | 1.80B | 2.23% | 458,183 | 292.09M |
| 261 | MD | Pediatrix Medical Group, Inc. | 1.80B | -2.48% | 509,958 | 1.93B |
| 262 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 4.18% | 718,696 | 217.17M |
| 263 | SION | Sionna Therapeutics, Inc. | 1.77B | 4.23% | 328,779 | - |
| 264 | OCUL | Ocular Therapeutix, Inc. | 1.77B | 1.13% | 3,995,651 | 52.04M |
| 265 | ANAB | AnaptysBio, Inc. | 1.75B | 0.85% | 317,765 | 232.39M |
| 266 | SGRY | Surgery Partners, Inc. | 1.75B | -1.21% | 691,712 | 3.34B |
| 267 | ANIP | ANI Pharmaceuticals, Inc. | 1.74B | 2.07% | 263,153 | 923.71M |
| 268 | UFPT | UFP Technologies, Inc. | 1.72B | 2.36% | 155,875 | 608.85M |
| 269 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 2.93% | 3,368,481 | 66.09M |
| 270 | ADUS | Addus HomeCare Corporation | 1.71B | 1.22% | 144,083 | 1.45B |
| 271 | SNDA | Sonida Senior Living, Inc. | 1.71B | 1.19% | 517,329 | 367.34M |
| 272 | RAPP | Rapport Therapeutics, Inc. | 1.71B | 3.84% | 206,230 | 20.00M |
| 273 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 2.78% | 481,230 | 66.05M |
| 274 | CAPR | Capricor Therapeutics, Inc. | 1.69B | 8.10% | 950,569 | 11.13M |
| 275 | NRIX | Nurix Therapeutics, Inc. | 1.68B | 6.76% | 1,152,024 | 71.78M |
| 276 | SLS | SELLAS Life Sciences Group, Inc. | 1.67B | 18.18% | 17,142,052 | - |
| 277 | GENB | Generate Biomedicines, Inc. | 1.66B | 4.27% | 797,733 | 30.30M |
| 278 | AVAH | Aveanna Healthcare Holdings Inc. | 1.66B | -0.20% | 1,123,670 | 2.52B |
| 279 | OCS | Oculis Holding AG | 1.65B | -0.14% | 375,421 | 1.40M |
| 280 | STAA | STAAR Surgical Company | 1.65B | 1.44% | 476,966 | 290.38M |
| 281 | INVA | Innoviva, Inc. | 1.64B | 2.30% | 693,615 | 420.69M |
| 282 | PVLA | Palvella Therapeutics, Inc. | 1.63B | 4.09% | 194,830 | - |
| 283 | INBX | Inhibrx Biosciences, Inc. | 1.61B | 0.16% | 399,046 | 1.30M |
| 284 | PRCT | PROCEPT BioRobotics Corporation | 1.59B | 7.80% | 1,121,437 | 322.02M |
| 285 | IOVA | Iovance Biotherapeutics, Inc. | 1.58B | 2.17% | 7,306,753 | 285.61M |
| 286 | TSHA | Taysha Gene Therapies, Inc. | 1.58B | 5.88% | 2,096,691 | 7.47M |
| 287 | GLUE | Monte Rosa Therapeutics, Inc. | 1.57B | 5.97% | 720,481 | 42.95M |
| 288 | NUVB | Nuvation Bio Inc. | 1.57B | 6.49% | 4,196,982 | 143.05M |
| 289 | RXRX | Recursion Pharmaceuticals, Inc. | 1.57B | 3.86% | 11,475,422 | 66.41M |
| 290 | QURE | uniQure N.V. | 1.56B | 0.28% | 748,907 | 18.09M |
| 291 | GHRS | GH Research PLC | 1.55B | 3.01% | 233,625 | - |
| 292 | ARDX | Ardelyx, Inc. | 1.55B | 2.96% | 2,125,044 | 427.68M |
| 293 | PRGO | Perrigo Company plc | 1.54B | 5.18% | 1,853,436 | 4.18B |
| 294 | PGEN | Precigen, Inc. | 1.53B | 3.00% | 2,609,680 | 31.60M |
| 295 | NVAX | Novavax, Inc. | 1.53B | 4.33% | 4,158,030 | 596.34M |
| 296 | ENOV | Enovis Corporation | 1.52B | 2.60% | 402,285 | 2.28B |
| 297 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.51B | 6.67% | 1,046,715 | -665.00K |
| 298 | MBX | MBX Biosciences, Inc. | 1.51B | 4.28% | 712,913 | - |
| 299 | IMCR | Immunocore Holdings plc | 1.50B | 2.00% | 439,453 | 412.81M |
| 300 | VIR | Vir Biotechnology, Inc. | 1.50B | 4.34% | 1,602,308 | 65.50M |
| 301 | IMTX | Immatics N.V. | 1.50B | 4.49% | 522,943 | 43.00M |
| 302 | ATAI | AtaiBeckley Inc. | 1.50B | 3.16% | 3,002,060 | 3.49M |
| 303 | URGN | UroGen Pharma Ltd. | 1.47B | 6.94% | 650,922 | 140.49M |
| 304 | ATRC | AtriCure, Inc. | 1.47B | 0.59% | 470,652 | 552.16M |
| 305 | CMPS | COMPASS Pathways plc | 1.46B | 7.65% | 3,686,043 | - |
| 306 | DMRA | Damora Therapeutics, Inc. | 1.46B | 0.79% | 152,823 | - |
| 307 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.17% | 5,218,936 | 114.48M |
| 308 | HCSG | Healthcare Services Group, Inc. | 1.42B | -0.24% | 381,853 | 1.85B |
| 309 | ALMR | Alamar Biosciences, Inc. | 1.41B | -0.68% | 167,891 | 87.16M |
| 310 | NNNN | Anbio Biotechnology | 1.41B | -0.71% | 23,466 | 8.65M |
| 311 | ABCL | AbCellera Biologics Inc. | 1.40B | 13.46% | 8,019,876 | 79.21M |
| 312 | AHCO | AdaptHealth Corp. | 1.39B | 0.87% | 796,845 | 3.29B |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.37B | 1.51% | 268,095 | 20.00M |
| 314 | PAHC | Phibro Animal Health Corporation | 1.37B | -0.09% | 372,222 | 1.50B |
| 315 | AHG | Akso Health Group | 1.37B | -1.84% | 2,478 | 14.84M |
| 316 | ARDT | Ardent Health, Inc. | 1.35B | -3.88% | 315,742 | 6.43B |
| 317 | BCAX | Bicara Therapeutics Inc. | 1.35B | 2.55% | 249,314 | - |
| 318 | AGL | agilon health, inc. | 1.34B | -8.76% | 390,698 | 5.82B |
| 319 | BHVN | Biohaven Ltd. | 1.33B | 5.66% | 2,257,063 | - |
| 320 | WGS | GeneDx Holdings Corp. | 1.33B | 6.29% | 901,337 | 442.68M |
| 321 | FTRE | Fortrea Holdings Inc. | 1.30B | -0.07% | 670,713 | 2.71B |
| 322 | SVRA | Savara Inc. | 1.29B | 7.84% | 896,714 | - |
| 323 | INSP | Inspire Medical Systems, Inc. | 1.27B | 3.57% | 568,181 | 915.25M |
| 324 | AVBP | ArriVent BioPharma, Inc. | 1.26B | 3.86% | 383,761 | - |
| 325 | ATEC | Alphatec Holdings, Inc. | 1.26B | - | 1,457,190 | 787.08M |
| 326 | SEPN | Septerna, Inc. | 1.26B | 5.13% | 168,534 | 72.26M |
| 327 | MPLT | MapLight Therapeutics, Inc. | 1.25B | 1.88% | 158,719 | - |
| 328 | MLTX | MoonLake Immunotherapeutics | 1.24B | 4.03% | 526,367 | - |
| 329 | PNTG | The Pennant Group, Inc. | 1.22B | 0.63% | 159,440 | 1.02B |
| 330 | ZBIO | Zenas BioPharma, Inc. | 1.22B | 8.35% | 435,092 | 10.00M |
| 331 | OLMA | Olema Pharmaceuticals, Inc. | 1.22B | 6.26% | 608,138 | - |
| 332 | KMTS | Kestra Medical Technologies, Ltd. | 1.21B | 4.90% | 256,730 | 83.72M |
| 333 | IART | Integra LifeSciences Holdings Corporation | 1.20B | 6.88% | 828,022 | 1.64B |
| 334 | WVE | Wave Life Sciences Ltd. | 1.19B | 0.57% | 3,711,268 | 71.80M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.18B | 4.51% | 1,182,170 | 101.66M |
| 336 | AVLN | Avalyn Pharma Inc. | 1.17B | -0.36% | 161,313 | - |
| 337 | TDOC | Teladoc Health, Inc. | 1.17B | -2.19% | 2,018,289 | 2.51B |
| 338 | JBIO | Jade Biosciences, Inc. | 1.16B | 7.40% | 522,010 | - |
| 339 | AVNS | Avanos Medical, Inc. | 1.16B | 0.04% | 464,616 | 715.90M |
| 340 | HROW | Harrow, Inc. | 1.15B | 0.85% | 387,674 | 268.68M |
| 341 | NEO | NeoGenomics, Inc. | 1.15B | 5.48% | 994,797 | 745.97M |
| 342 | COAG | Hemab Therapeutics Holdings, Inc. | 1.15B | 2.48% | 146,138 | - |
| 343 | BFLY | Butterfly Network, Inc. | 1.15B | 7.20% | 4,333,177 | 102.92M |
| 344 | IRMD | IRADIMED CORPORATION | 1.14B | 2.31% | 146,426 | 86.28M |
| 345 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.13B | 4.03% | 3,046,322 | 204.73M |
| 346 | COLL | Collegium Pharmaceutical, Inc. | 1.11B | 2.14% | 205,359 | 796.33M |
| 347 | DBVT | DBV Technologies S.A. | 1.11B | -0.22% | 81,709 | 5.74M |
| 348 | CNMD | CONMED Corporation | 1.11B | 1.66% | 215,007 | 1.37B |
| 349 | AORT | Artivion, Inc. | 1.10B | -0.73% | 690,387 | 458.69M |
| 350 | CDNA | CareDx, Inc. | 1.09B | 3.12% | 1,050,305 | 412.82M |
| 351 | XERS | Xeris Biopharma Holdings, Inc. | 1.07B | 5.15% | 1,126,736 | 314.85M |
| 352 | IVA | Inventiva S.A. | 1.07B | 4.18% | 142,561 | 7.94M |
| 353 | AKTS | Aktis Oncology, Inc. | 1.05B | 2.92% | 83,086 | 8.28M |
| 354 | EYPT | EyePoint, Inc. | 1.05B | 6.09% | 741,512 | 7.61M |
| 355 | AMN | AMN Healthcare Services, Inc. | 1.04B | -0.41% | 855,592 | 3.42B |
| 356 | ALVO | Alvotech | 1.03B | 0.76% | 364,691 | 562.04M |
| 357 | TNDM | Tandem Diabetes Care, Inc. | 1.03B | 8.04% | 1,186,546 | 1.03B |
| 358 | CRVS | Corvus Pharmaceuticals, Inc. | 1.02B | 5.83% | 1,829,622 | - |
| 359 | INNV | InnovAge Holding Corp. | 1.01B | 3.54% | 250,291 | 949.17M |
| 360 | EVO | Evotec SE | 1.01B | 2.70% | 31,990 | 859.03M |
| 361 | MNKD | MannKind Corporation | 1.00B | 9.63% | 3,993,045 | 360.78M |
| 362 | DRTS | Alpha Tau Medical Ltd. | 981.75M | 4.45% | 1,184,352 | - |
| 363 | LXRX | Lexicon Pharmaceuticals, Inc. | 979.25M | 3.52% | 1,472,393 | 69.64M |
| 364 | CRON | Cronos Group Inc. | 978.71M | 2.49% | 2,222,467 | 159.54M |
| 365 | OMDA | Omada Health, Inc. | 977.33M | -0.96% | 517,473 | 283.30M |
| 366 | USPH | U.S. Physical Therapy, Inc. | 945.70M | 0.86% | 170,407 | 787.69M |
| 367 | PHAT | Phathom Pharmaceuticals, Inc. | 942.84M | 4.12% | 843,852 | 204.89M |
| 368 | ETON | Eton Pharmaceuticals, Inc. | 941.75M | 4.53% | 423,575 | 86.93M |
| 369 | OPK | OPKO Health, Inc. | 924.99M | 6.52% | 2,551,137 | 581.12M |
| 370 | SDGR | Schrรถdinger, Inc. | 920.56M | 2.75% | 1,033,722 | 254.91M |
| 371 | KURA | Kura Oncology, Inc. | 916.15M | 15.18% | 4,856,012 | 71.64M |
| 372 | BVS | Bioventus Inc. | 913.04M | 2.53% | 290,472 | 576.30M |
| 373 | PCRX | Pacira BioSciences, Inc. | 907.76M | 3.41% | 406,328 | 734.86M |
| 374 | OMER | Omeros Corporation | 898.90M | 3.76% | 872,328 | 9.89M |
| 375 | PHAR | Pharming Group N.V. | 895.41M | 3.17% | 6,261 | 369.49M |
| 376 | MGTX | MeiraGTx Holdings plc | 889.05M | 5.15% | 653,815 | 79.76M |
| 377 | INMD | InMode Ltd. | 886.39M | 0.14% | 722,353 | 374.64M |
| 378 | CGEM | Cullinan Therapeutics, Inc. | 880.08M | 1.02% | 850,858 | - |
| 379 | JANX | Janux Therapeutics, Inc. | 878.17M | 4.27% | 849,059 | 13.73M |
| 380 | TALK | Talkspace, Inc. | 870.23M | -0.10% | 1,308,751 | 238.37M |
| 381 | ORIC | ORIC Pharmaceuticals, Inc. | 867.48M | 5.14% | 600,421 | - |
| 382 | SANA | Sana Biotechnology, Inc. | 866.88M | 1.80% | 2,377,812 | - |
| 383 | ABUS | Arbutus Biopharma Corporation | 862.25M | 3.93% | 2,092,401 | 191.45M |
| 384 | AZTA | Azenta, Inc. | 853.64M | 4.93% | 1,397,183 | 596.48M |
| 385 | TBPH | Theravance Biopharma, Inc. | 852.17M | 1.72% | 341,105 | 109.78M |
| 386 | GDRX | GoodRx Holdings, Inc. | 851.77M | -0.20% | 930,957 | 787.89M |
| 387 | SPTX | Seaport Therapeutics, Inc. | 841.02M | 1.28% | 233,211 | - |
| 388 | XNCR | Xencor, Inc. | 840.77M | 8.93% | 679,696 | 97.36M |
| 389 | VOR | Vor Biopharma Inc. | 839.34M | 9.62% | 1,271,506 | - |
| 390 | NUTX | Nutex Health Inc. | 831.82M | -4.36% | 136,375 | 879.95M |
| 391 | PSNL | Personalis, Inc. | 831.49M | 12.78% | 2,440,251 | 64.52M |
| 392 | AURA | Aura Biosciences, Inc. | 826.14M | 1.35% | 371,935 | - |
| 393 | ANNX | Annexon, Inc. | 824.95M | 2.55% | 1,461,946 | - |
| 394 | GERN | Geron Corporation | 811.52M | 3.69% | 6,983,497 | 196.12M |
| 395 | QDEL | QuidelOrtho Corporation | 811.47M | 4.57% | 1,548,717 | 2.66B |
| 396 | CTMX | CytomX Therapeutics, Inc. | 810.94M | 2.34% | 1,743,651 | 35.54M |
| 397 | ESPR | Esperion Therapeutics, Inc. | 807.05M | 0.16% | 7,301,457 | 418.24M |
| 398 | LBRX | LB Pharmaceuticals Inc | 802.95M | 2.68% | 147,681 | - |
| 399 | AVTX | Avalo Therapeutics, Inc. | 801.09M | 0.37% | 1,075,329 | 59.00K |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 798.08M | 1.57% | 685,150 | 720.53M |
| 401 | EVMN | Evommune, Inc. | 796.01M | 4.64% | 233,998 | 10.00M |
| 402 | ODTX | Odyssey Therapeutics, Inc. | 795.36M | -0.47% | 327,418 | 2.98M |
| 403 | SSII | SS Innovations International, Inc. | 788.76M | -1.38% | 33,993 | 48.47M |
| 404 | SPRY | ARS Pharmaceuticals, Inc. | 773.57M | 8.65% | 1,274,057 | 98.99M |
| 405 | ABSI | Absci Corporation | 772.51M | 7.02% | 2,973,907 | 1.84M |
| 406 | AVR | Anteris Technologies Global Corp. | 770.29M | 11.95% | 1,495,963 | 1.85M |
| 407 | RLMD | Relmada Therapeutics, Inc. | 749.95M | 1.71% | 647,585 | - |
| 408 | DRUG | Bright Minds Biosciences Inc. | 739.49M | 10.25% | 184,389 | - |
| 409 | SGP | SpyGlass Pharma, Inc. | 735.05M | 3.73% | 28,783 | - |
| 410 | CERT | Certara, Inc. | 727.26M | 1.85% | 2,571,951 | 419.75M |
| 411 | ANRO | Alto Neuroscience, Inc. | 724.54M | 1.08% | 164,465 | - |
| 412 | BIOA | BioAge Labs, Inc. | 717.47M | -1.41% | 265,608 | 10.32M |
| 413 | LMRI | Lumexa Imaging Holdings, Inc. | 711.00M | 5.71% | 1,292,315 | 1.03B |
| 414 | TENX | Tenax Therapeutics, Inc. | 709.48M | 5.01% | 294,732 | - |
| 415 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 707.49M | 1.38% | 388,645 | - |
| 416 | HSTM | HealthStream, Inc. | 699.41M | -2.01% | 218,509 | 311.78M |
| 417 | DSGN | Design Therapeutics, Inc. | 695.77M | 6.20% | 2,263,869 | - |
| 418 | CBLL | CeriBell, Inc. | 684.87M | 6.43% | 273,627 | 95.07M |
| 419 | SIBN | SI-BONE, Inc. | 657.26M | -0.13% | 290,441 | 206.22M |
| 420 | ALLO | Allogene Therapeutics, Inc. | 654.07M | 0.26% | 4,564,324 | 22.00K |
| 421 | IRWD | Ironwood Pharmaceuticals, Inc. | 646.93M | 7.08% | 2,742,974 | 361.51M |
| 422 | TLRY | Tilray Brands, Inc. | 645.32M | 3.84% | 2,413,704 | 858.28M |
| 423 | CBIO | Crescent Biopharma, Inc. | 638.00M | 3.90% | 90,788 | 11.88M |
| 424 | SLDB | Solid Biosciences Inc. | 635.98M | 6.25% | 901,677 | - |
| 425 | ACRS | Aclaris Therapeutics, Inc. | 633.37M | 1.91% | 849,731 | 8.37M |
| 426 | CRMD | CorMedix Inc. | 624.08M | 1.73% | 1,192,224 | 400.05M |
| 427 | CSTL | Castle Biosciences, Inc. | 606.60M | 4.17% | 268,511 | 339.92M |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 604.75M | 0.29% | 755,190 | 122.29M |
| 429 | BWAY | BrainsWay Ltd. | 600.41M | 2.28% | 91,057 | 56.22M |
| 430 | ARVN | Arvinas, Inc. | 585.53M | 6.14% | 653,963 | 89.40M |
| 431 | EIKN | Eikon Therapeutics, Inc. | 578.20M | 0.38% | 212,854 | - |
| 432 | CADL | Candel Therapeutics, Inc. | 572.61M | 2.02% | 1,203,318 | - |
| 433 | TRAX | First Tracks Biotherapeutics, Inc. | 568.75M | -2.16% | 416,023 | - |
| 434 | MDXG | MiMedx Group, Inc. | 565.25M | 4.26% | 893,641 | 389.42M |
| 435 | CABA | Cabaletta Bio, Inc. | 561.71M | 5.35% | 3,013,682 | - |
| 436 | TCMD | Tactile Systems Technology, Inc. | 559.40M | 2.23% | 132,188 | 343.52M |
| 437 | NPCE | NeuroPace, Inc. | 556.41M | 2.97% | 148,650 | 99.53M |
| 438 | GYRE | Gyre Therapeutics, Inc. | 554.63M | -3.04% | 88,404 | 117.05M |
| 439 | ALT | Altimmune, Inc. | 549.39M | 3.10% | 1,769,865 | 36.00K |
| 440 | VALN | Valneva SE | 549.16M | 2.60% | 62,103 | 180.25M |
| 441 | CERS | Cerus Corporation | 538.99M | -0.37% | 2,569,251 | 216.56M |
| 442 | TECX | Tectonic Therapeutic, Inc. | 538.72M | 4.62% | 114,268 | - |
| 443 | PHR | Phreesia, Inc. | 537.15M | -3.60% | 1,520,150 | 480.59M |
| 444 | RIGL | Rigel Pharmaceuticals, Inc. | 531.19M | 1.45% | 234,378 | 299.77M |
| 445 | XOMA | XOMA Royalty Corporation | 526.10M | 0.99% | 92,720 | 48.56M |
| 446 | AQST | Aquestive Therapeutics, Inc. | 525.01M | 2.32% | 1,032,281 | 50.27M |
| 447 | AGMB | AgomAb Therapeutics NV | 520.06M | 0.48% | 33,969 | - |
| 448 | KYTX | Kyverna Therapeutics, Inc. | 519.35M | -1.38% | 729,432 | - |
| 449 | PROK | ProKidney Corp. | 517.86M | 10.65% | 1,201,820 | 889.00K |
| 450 | STRO | Sutro Biopharma, Inc. | 515.76M | -1.71% | 340,317 | 99.61M |
| 451 | PRME | Prime Medicine, Inc. | 512.95M | 5.19% | 1,863,856 | 4.03M |
| 452 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 453 | DNA | Ginkgo Bioworks Holdings, Inc. | 502.67M | 4.55% | 563,110 | 151.40M |
| 454 | CTNM | Contineum Therapeutics, Inc. | 502.47M | 5.33% | 179,209 | - |
| 455 | CLYM | Climb Bio, Inc. | 501.09M | 8.70% | 559,988 | - |
| 456 | FBRX | Forte Biosciences, Inc. | 497.27M | 1.40% | 102,859 | - |
| 457 | ANGO | AngioDynamics, Inc. | 491.02M | 2.97% | 321,675 | 313.73M |
| 458 | OFIX | Orthofix Medical Inc. | 490.72M | 0.41% | 228,313 | 825.37M |
| 459 | PRTA | Prothena Corporation plc | 488.19M | 2.81% | 433,235 | 57.94M |
| 460 | CTKB | Cytek Biosciences, Inc. | 486.22M | 5.46% | 705,374 | 204.17M |
| 461 | SRTA | Strata Critical Medical, Inc. | 478.49M | 5.94% | 681,412 | 228.58M |
| 462 | IMMX | Immix Biopharma, Inc. | 473.93M | 0.90% | 569,557 | - |
| 463 | KIDS | OrthoPediatrics Corp. | 473.89M | 1.21% | 85,816 | 243.30M |
| 464 | ANL | Adlai Nortye Ltd. | 468.40M | 9.44% | 252,428 | 5.00M |
| 465 | WEAV | Weave Communications, Inc. | 468.24M | 1.47% | 919,688 | 248.72M |
| 466 | ACHV | Achieve Life Sciences, Inc. | 467.10M | 2.25% | 1,004,695 | - |
| 467 | FLGT | Fulgent Genetics, Inc. | 466.34M | 2.95% | 403,101 | 320.35M |
| 468 | STTK | Shattuck Labs, Inc. | 462.56M | 5.70% | 272,058 | 1.00M |
| 469 | UPB | Upstream Bio, Inc. | 459.85M | 5.23% | 487,687 | 3.32M |
| 470 | OCGN | Ocugen, Inc. | 458.70M | 4.23% | 3,545,751 | 4.47M |
| 471 | VTVT | vTv Therapeutics Inc. | 455.43M | 0.58% | 53,261 | 36.84M |
| 472 | BBNX | Beta Bionics, Inc. | 454.08M | 8.17% | 527,387 | 110.24M |
| 473 | PRLD | Prelude Therapeutics Incorporated | 452.60M | 5.39% | 343,922 | 16.72M |
| 474 | FDMT | 4D Molecular Therapeutics, Inc. | 445.39M | 1.37% | 380,923 | 88.24M |
| 475 | KMDA | Kamada Ltd. | 445.10M | 3.82% | 65,830 | 181.68M |
| 476 | EVH | Evolent Health, Inc. | 434.18M | -0.77% | 2,168,647 | 1.89B |
| 477 | NRC | NRC Health | 432.70M | 2.40% | 123,208 | 138.64M |
| 478 | AUTL | Autolus Therapeutics plc | 432.48M | -0.31% | 876,546 | 92.62M |
| 479 | EOLS | Evolus, Inc. | 431.35M | 1.87% | 569,617 | 301.79M |
| 480 | NGNE | Neurogene Inc. | 427.92M | 0.74% | 139,731 | 925.00K |
| 481 | CATX | Perspective Therapeutics, Inc. | 427.67M | 3.31% | 668,771 | 618.00K |
| 482 | MNPR | Monopar Therapeutics Inc. | 426.51M | 15.34% | 304,887 | - |
| 483 | REPL | Replimune Group, Inc. | 425.25M | 9.57% | 5,274,685 | - |
| 484 | FULC | Fulcrum Therapeutics, Inc. | 424.45M | 7.78% | 393,892 | 80.00M |
| 485 | PRTC | PureTech Health plc | 423.21M | 4.04% | 6,580 | 4.66M |
| 486 | EBS | Emergent BioSolutions Inc. | 422.57M | 1.61% | 440,870 | 676.80M |
| 487 | VREX | Varex Imaging Corporation | 422.31M | 7.51% | 364,008 | 857.50M |
| 488 | TOI | The Oncology Institute, Inc. | 419.93M | 2.44% | 2,602,015 | 545.76M |
| 489 | ASMB | Assembly Biosciences, Inc. | 419.41M | -0.49% | 111,923 | 71.10M |
| 490 | MOBI | Mobia Medical, Inc. | 415.22M | 0.72% | 58,895 | 32.04M |
| 491 | OVID | Ovid Therapeutics Inc. | 413.56M | -0.42% | 817,799 | 7.12M |
| 492 | ADCT | ADC Therapeutics SA | 411.46M | 3.03% | 539,204 | 79.18M |
| 493 | SGMT | Sagimet Biosciences Inc. | 410.65M | 1.68% | 582,015 | - |
| 494 | LAB | Standard BioTools Inc. | 409.89M | 5.00% | 1,200,608 | 86.26M |
| 495 | CCRN | Cross Country Healthcare, Inc. | 406.67M | 0.11% | 533,998 | 1.00B |
| 496 | IPSC | Century Therapeutics, Inc. | 405.80M | 6.13% | 440,899 | 109.16M |
| 497 | LXEO | Lexeo Therapeutics, Inc. | 402.82M | 14.51% | 1,599,546 | - |
| 498 | LYEL | Lyell Immunopharma, Inc. | 399.69M | 6.20% | 68,868 | 31.00K |
| 499 | ENTA | Enanta Pharmaceuticals, Inc. | 394.88M | -1.31% | 109,655 | 69.21M |
| 500 | EPRX | Eupraxia Pharmaceuticals Inc. | 391.44M | 0.64% | 193,772 | - |